BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32960872)

  • 1. Drugs for COPD.
    Med Lett Drugs Ther; 2020 Sep; 62(1606):137-144. PubMed ID: 32960872
    [No Abstract]   [Full Text] [Related]  

  • 2. Table: Correct Use of inhalers for COPD.
    Med Lett Drugs Ther; 2020 Sep; 62(1606):e150-e154. PubMed ID: 32960876
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison table: Inhaled long-acting bronchodilators for treatment of COPD.
    Med Lett Drugs Ther; 2020 Sep; 62(1606):e146-e147. PubMed ID: 32960874
    [No Abstract]   [Full Text] [Related]  

  • 4. Expanded table: Correct use of inhalers for asthma.
    Med Lett Drugs Ther; 2020 Dec; 62(1613):e204-e208. PubMed ID: 33446624
    [No Abstract]   [Full Text] [Related]  

  • 5. Drugs for asthma.
    Med Lett Drugs Ther; 2020 Dec; 62(1613):193-200. PubMed ID: 33446622
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison table: Inhaled corticosteroids for treatment of COPD.
    Med Lett Drugs Ther; 2020 Sep; 62(1606):e148-e149. PubMed ID: 32960875
    [No Abstract]   [Full Text] [Related]  

  • 7. Expanded table: Some inhaled drugs for treatment of asthma.
    Med Lett Drugs Ther; 2020 Dec; 62(1613):e200-e203. PubMed ID: 33446623
    [No Abstract]   [Full Text] [Related]  

  • 8. Duaklir Pressair: another LAMA/LABA inhaler for COPD.
    Med Lett Drugs Ther; 2019 Sep; 61(1581):149-151. PubMed ID: 31599867
    [No Abstract]   [Full Text] [Related]  

  • 9. Trelegy Ellipta--a three-drug inhaler for COPD.
    Med Lett Drugs Ther; 2018 May; 60(1547):86-88. PubMed ID: 29913467
    [No Abstract]   [Full Text] [Related]  

  • 10. Revefenacin (Yupelri) for COPD.
    Med Lett Drugs Ther; 2019 Jan; 61(1564):14-15. PubMed ID: 30856160
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison table: Inhaled short-acting bronchodilators for treatment of COPD.
    Med Lett Drugs Ther; 2020 Sep; 62(1606):e144-e145. PubMed ID: 32960873
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the finnish guidelines.
    Kankaanranta H; Harju T; Kilpeläinen M; Mazur W; Lehto JT; Katajisto M; Peisa T; Meinander T; Lehtimäki L
    Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):291-307. PubMed ID: 25515181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nebulized glycopyrrolate (Lonhala Magnair) for COPD.
    Med Lett Drugs Ther; 2018 Apr; 60(1543):72. PubMed ID: 29667949
    [No Abstract]   [Full Text] [Related]  

  • 14. Correlation of Inhaled Long-Acting Bronchodilators With Adverse Cardiovascular Outcomes in Patients With Stable COPD: A Bayesian Network Meta-Analysis of Randomized Controlled Trials.
    Wu J; Ye Y; Li C; Zhou W; Chang R
    J Cardiovasc Pharmacol; 2019 Sep; 74(3):255-265. PubMed ID: 31306366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.
    Prescrire Int; 2016 Nov; 25(176):272-277. PubMed ID: 30715829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy with indacaterol and glycopyrronium bromide in the management of COPD: an update on the evidence for efficacy and safety.
    Ridolo E; Montagni M; Riario-Sforza GG; Baroni M; Incorvaia C
    Ther Adv Respir Dis; 2015 Apr; 9(2):49-55. PubMed ID: 25691493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fixed-dose combination of umeclidinium and vilanterol for patients with chronic obstructive pulmonary disease: A systematic review.
    Ramadan WH; Al Masri S; Rizk J
    Clin Respir J; 2019 Nov; 13(11):663-673. PubMed ID: 31389190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ▼Olodaterol--another LABA for COPD.
    Drug Ther Bull; 2015 Apr; 53(4):42-5. PubMed ID: 25858815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide.
    Singh D; Corradi M; Spinola M; Papi A; Usmani OS; Scuri M; Petruzzelli S; Vestbo J
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2917-2928. PubMed ID: 29062229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spotlight on fluticasone furoate/umeclidinium/vilanterol in COPD: design, development, and potential place in therapy.
    Lal C; Strange C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():135-140. PubMed ID: 28115838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.